2023-509027-41-00CompletedPhase 1
A study to investigate the safety and tolerability of dostarlimab in adult participants with chronic HBV infection on nucleos(t)ide analogue (NA) treatment
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Nov 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- First submitted
- 26 Jul 2024
- Start date
- 8 Nov 2024
- Lead sponsor
- Glaxosmithkline Research & Development Limited
- Diseases
- Hepatitis B
- EU CT number
- 2023-509027-41-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 23
- 11 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (11)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Diagnostic-Consultative Center Alexandrovska EOOD | Sofiya | Bulgaria | Completed |
| Diagnostics-Consultancy Center Mladost M Varna OOD | Varna | Bulgaria | Completed |
| University Hospital Son Espases | Palma | Spain | Completed |
| Hospital Universitario Marqués de Valdecilla | Santander | Spain | Completed |
| University Hospital Virgen Del Rocio S.L. | Sevilla | Spain | Completed |
| Hopital Beaujon | Clichy | France | Completed |
| Hospices Civils De Lyon | Lyon Cedex 04 | France | Completed |
| Les Hopitaux Universitaires De Strasbourg | Strasbourg Cedex | France | Completed |
| Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII | Bergamo | Italy | Completed |
| Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico | Milan | Italy | Completed |
| Fondazione IRCCS San Gerardo dei Tintori | Monza | Italy | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.